AQR Arbitrage’s SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an SCPE.WS Stock Holding History

AQR Arbitrage’s Portfolio SCPE.WS Stock Details SCPE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-235,428	Closed	-$497K	–	1401
2021 Q2	$497K	Hold	235,428	–	–	0.01%	621
2021 Q1	$445K	Sell	235,428 -64,572	-22%	-$105K	0.02%	605
2020 Q4	$405K	Hold	300,000	–	–	0.01%	738
2020 Q3	$345K	Hold	300,000	–	–	0.01%	453
2020 Q2	$324K	Hold	300,000	–	–	0.01%	400
2020 Q1	$287K	Hold	300,000	–	–	0.01%	409
2019 Q4	$288K	Hold	300,000	–	–	﹤0.01%	388
2019 Q3	$360K	Buy	+300,000	New	+$354K	0.01%	362

AQR Arbitrage's SCPE.WS Position: Q3 2021 in Review

AQR Arbitrage sold out of SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an (SCPE.WS) in Q3 2021, closing a stake of 235,428 shares — an estimated $497K sold.

AQR Arbitrage first reported a position in SCPE.WS in Q3 2019 and held it in 8 quarters. The position peaked at $497K in Q2 2021. 0 funds tracked by Wall St. Rank hold SCPE.WS as of Q3 2021.

AQR Arbitrage reported no remaining SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position as of Q3 2021 after selling out during the quarter.
AQR Arbitrage sold 235,428 SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an shares in Q3 2021, an estimated $497K.
AQR Arbitrage first reported a position in SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an in Q3 2019 and held it in 8 quarters.
AQR Arbitrage's SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position peaked at $497K in Q2 2021.
0 funds tracked by Wall St. Rank held SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an as of Q3 2021.

Based on AQR Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.